Go Or No-Go, Glaucoma Co.?
Executive Summary
To mark World Glaucoma Week, Medtech Insight takes a look back at some of the innovators in the field that caught investors' interest over the past five years to see how these businesses are doing in their fight against this disease.
You may also be interested in...
Device Week, March 15, 2018 – Israeli Medtech Industry, Glaucoma Week, February VC Deals Update
On this week's Device Week podcast, we discuss the medtech scene in Israel, the state of the glaucoma-therapy field, and the latest venture capital investments in medtech.
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.